GlassScriptPhysician profile
Girish H Mehta
NPI 1508854787
$13,338.94
in general payments reported to CMS, 2019-2025
53 companies · $2,504 in 2025
The $2,504 reported for 2025 was more than what 80% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,923 · 2020: $989 · 2021: $1,689 · 2022: $2,262 · 2023: $1,699 · 2024: $2,273 · 2025: $2,504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,476.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,000.75 | 2019-2025 | Breztri, Airsupra, Tezspire |
| Glaxosmithkline, LLC. | $1,990.51 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,921.17 | 2019-2025 | Ofev, Spiriva Respimat, Jascayd |
| United Therapeutics Corporation | $780.29 | 2019-2025 | Tyvaso, Tyvaso |
| Genzyme Corporation | $622.24 | 2019-2025 | |
| Electromed, INC. | $515.27 | 2019-2025 | Smartvest |
| Regeneron Healthcare Solutions, INC. | $494.23 | 2019-2025 | Dupixent |
| Genentech USA, INC. | $474.47 | 2019-2025 | Xolair |
| Actelion Pharmaceuticals US, INC. | $465.15 | 2019-2023 | Uptravi, Opsumit |
| Takeda Pharmaceuticals U.S.A., INC. | $414.54 | 2020-2025 | Glassia |
| Mylan Specialty L.P. | $393.65 | 2019-2024 | Yupelri |
| Insmed, INC. | $293.26 | 2019-2025 | Arikayce, Brinsupri |
| Pulmonx Corporation | $291.37 | 2019-2024 | Chartis Catheter, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Merck Sharp & Dohme LLC | $259.20 | 2020-2025 | Winrevair, Zerbaxa, Keytruda |
| Baxter Healthcare | $229.81 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $214.13 | 2019-2021 | |
| Philips North America LLC | $190.68 | 2019-2024 | (Di7) Home Pi Undivided |
| Amgen INC. | $168.12 | 2020-2025 | Tezspire, Evenity, Prolia |
| Pfizer INC. | $141.80 | 2019-2025 | |
| Mallinckrodt Hospital Products INC. | $127.64 | 2021-2023 | Acthar |
| Sunovion Pharmaceuticals INC. | $104.47 | 2019 | |
| Medtronic, INC. | $99.93 | 2024 | Kyphon Express II Kyphopak Tray |
| Viatris Specialty LLC | $99.82 | 2025 | Yupelri |
| Verona Pharma, INC. | $85.80 | 2025 | Ohtuvayre |
| Abbott Laboratories | $79.54 | 2022-2024 | Assurity, Prodigy |
| Amarin Pharma, INC. | $60.98 | 2021 | |
| Penumbra, INC. | $57.08 | 2023 | Indigo System |
| Gilead Sciences, INC. | $56.85 | 2019-2022 | |
| Shire North American Group INC | $56.49 | 2019 | |
| Harmony Biosciences LLC | $51.72 | 2022-2023 | Wakix |
| Vifor Pharma, INC. | $51.47 | 2024 | Zemaira |
| Inogen, INC. | $51.38 | 2023-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Eisai INC. | $43.56 | 2020 | |
| Lilly USA, LLC | $39.74 | 2025 | Zepbound |
| Advanced Respiratory, INC | $35.81 | 2020-2021 | |
| Ani Pharmaceuticals, INC. | $31.18 | 2025 | Purified Cortrophin Gel |
| Teleflex LLC | $30.32 | 2022 | |
| Novartis Pharmaceuticals Corporation | $28.41 | 2025 | |
| Paratek Pharmaceuticals, INC. | $28.14 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $28.08 | 2020-2023 | Seglentis |
| Jazz Pharmaceuticals INC. | $25.65 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.15 | 2023 | |
| Edwards Lifesciences Corporation | $23.12 | 2022 | |
| Janssen Pharmaceuticals, INC | $18.99 | 2019 | |
| Abbvie INC. | $18.53 | 2025 | |
| Boston Scientific Corporation | $18.45 | 2023 | |
| Strongbridge US INC. | $16.63 | 2020 | |
| Mayne Pharma Commercial LLC | $16.20 | 2019 | |
| Medtronic USA, INC. | $14.92 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.68 | 2019 | |
| Circassia INC. | $14.36 | 2020 | |
| Seqirus USA INC | $13.77 | 2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Breas Medical, INC. | $11.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Girish Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.